Literature DB >> 21639698

Prophylactic antiepileptic drug therapy in patients undergoing supratentorial meningioma resection: a systematic analysis of efficacy.

Ricardo J Komotar1, Daniel M S Raper, Robert M Starke, J Bryan Iorgulescu, Philip H Gutin.   

Abstract

OBJECT: Meningiomas are one of the more common intracranial neoplasms. The risk of seizures and secondary aspiration, brain edema, and brain injury often leads practitioners to administer prophylactic antiepileptic drugs (AEDs) perioperatively. The efficacy of this practice remains controversial, however, with prior investigations reaching conflicting results and recent studies focusing on AED side effects. The authors performed a systematic analysis of outcomes following supratentorial meningioma resection with and without prophylactic AED administration in the hope of clarifying the role of AEDs in the perioperative care of patients with these lesions.
METHODS: A MEDLINE search of the literature (1979-2010) was performed. Comparisons were made for patient and tumor characteristics as well as success of repair, morbidity, and seizure outcome. Statistical analyses of categorical variables were undertaken using chi-square and Fisher exact tests.
RESULTS: Nineteen studies, involving 698 patients, were included. There were no significant differences in the extent of resection, perioperative mortality, or recurrence between the AED and no-AED cohorts. Likewise, there were no significant differences in the incidence of early or late seizures between the cohorts.
CONCLUSIONS: The results of this systematic analysis supports the conclusion that the prophylactic administration of anticonvulsants during resection of supratentorial meningiomas provides no benefit in the prevention of either early or late postoperative seizures. Despite their traditional role in this patient population, the routine use of AEDs should be carefully reconsidered.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21639698     DOI: 10.3171/2011.4.JNS101585

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  15 in total

1.  Risk factors and control of seizures in 778 Chinese patients undergoing initial resection of supratentorial meningiomas.

Authors:  Xiangrong Li; Chengjun Wang; Zhiqin Lin; Meng Zhao; Xiaohui Ren; Xiaohui Zhang; Zhongli Jiang
Journal:  Neurosurg Rev       Date:  2019-02-15       Impact factor: 3.042

2.  Management of epilepsy in brain tumors.

Authors:  Marta Maschio; Umberto Aguglia; Giuliano Avanzini; Paola Banfi; Carla Buttinelli; Giuseppe Capovilla; Marina Maria Luisa Casazza; Gabriella Colicchio; Antonietta Coppola; Cinzia Costa; Filippo Dainese; Ornella Daniele; Roberto De Simone; Marica Eoli; Sara Gasparini; Anna Teresa Giallonardo; Angela La Neve; Andrea Maialetti; Oriano Mecarelli; Marta Melis; Roberto Michelucci; Francesco Paladin; Giada Pauletto; Marta Piccioli; Stefano Quadri; Federica Ranzato; Rosario Rossi; Andrea Salmaggi; Riccardo Terenzi; Paolo Tisei; Flavio Villani; Paolo Vitali; Lucina Carla Vivalda; Gaetano Zaccara; Alessia Zarabla; Ettore Beghi
Journal:  Neurol Sci       Date:  2019-08-07       Impact factor: 3.307

3.  Factors Associated With Pre- and Postoperative Seizures in 1033 Patients Undergoing Supratentorial Meningioma Resection.

Authors:  William C Chen; Stephen T Magill; Dario J Englot; Joe D Baal; Sagar Wagle; Jonathan W Rick; Michael W McDermott
Journal:  Neurosurgery       Date:  2017-08-01       Impact factor: 4.654

Review 4.  Meningioma Related Epilepsy- Pathophysiology, Pre/postoperative Seizures Predicators and Treatment.

Authors:  Rasha Elbadry Ahmed; Hailiang Tang; Anthony Asemota; Lei Huang; Warren Boling; Firas Bannout
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

5.  Early and late postoperative seizure outcome in 97 patients with supratentorial meningioma and preoperative seizures: a retrospective study.

Authors:  Zhe Zheng; Peng Chen; Weiming Fu; Junming Zhu; Hong Zhang; Jian Shi; Jianmin Zhang
Journal:  J Neurooncol       Date:  2013-05-24       Impact factor: 4.130

Review 6.  Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis.

Authors:  Chryssa Pourzitaki; Georgia Tsaousi; Eirini Apostolidou; Konstantinos Karakoulas; Dimitrios Kouvelas; Ekaterini Amaniti
Journal:  Br J Clin Pharmacol       Date:  2016-04-24       Impact factor: 4.335

Review 7.  Seizures in supratentorial meningioma: a systematic review and meta-analysis.

Authors:  Dario J Englot; Stephen T Magill; Seunggu J Han; Edward F Chang; Mitchel S Berger; Michael W McDermott
Journal:  J Neurosurg       Date:  2015-12-04       Impact factor: 5.115

Review 8.  Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy.

Authors:  Terri S Armstrong; Robin Grant; Mark R Gilbert; Jong Woo Lee; Andrew D Norden
Journal:  Neuro Oncol       Date:  2015-11-02       Impact factor: 12.300

9.  Incidence, risk factors and outcomes of seizures occurring after craniotomy for primary brain tumor resection.

Authors:  Hasan M Al-Dorzi; Abdullah A Alruwaita; Bothaina O Marae; Bushra S Alraddadi; Hani M Tamim; Ahmad Ferayan; Yaseen M Arabi
Journal:  Neurosciences (Riyadh)       Date:  2017-04       Impact factor: 0.906

10.  Levetiracetam seizure prophylaxis in craniotomy patients at high risk for postoperative seizures.

Authors:  Sankalp Gokhale; Shariq Ali Khan; Abhishek Agrawal; Allan H Friedman; David L McDonagh
Journal:  Asian J Neurosurg       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.